Evidence map›Paper›PMID 30507971›Full record

ArticlePLoS genetics2018

Amino acid residues in five separate HLA genes can explain most of the known associations between the MHC and primary biliary cholangitis.

Rebecca Darlay, Kristin L Ayers, George F Mells, Lynsey S Hall, Jimmy Z Liu, Mohamed A Almarri, Graeme J Alexander, David E Jones, Richard N Sandford, Carl A Anderson and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Rebecca DarlayInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.ORCID 0000-0002-7526-5527
Kristin L AyersInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
George F MellsAcademic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
Lynsey S HallInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.ORCID 0000-0002-0624-5303
Jimmy Z LiuHuman Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.
Mohamed A AlmarriHuman Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.ORCID 0000-0003-1255-0918
Graeme J AlexanderDepartment of Hepatology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, United Kingdom.ORCID 0000-0002-9713-1394
David E JonesInstitute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom.
Richard N SandfordAcademic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
Carl A AndersonHuman Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.ORCID 0000-0003-1719-7009
Heather J CordellInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.ORCID 0000-0002-1879-5572
Newcastle University · GBWellcome Sanger Institute · GBUniversity of Cambridge · GBCardiff University · GBNational Health Service · GB

Funding

Medical Research Council MR/L001489/1Wellcome Trust 085925/Z/08/ZWellcome Trust 098051Wellcome Trust 102858/Z/13/ZWellcome Trust WT090355/A/09/ZWellcome Trust WT090355/B/09/Z
6 · The paper itself

Abstract

Primary Biliary Cholangitis (PBC) is a chronic autoimmune liver disease characterised by progressive destruction of intrahepatic bile ducts. The strongest genetic association is with HLA-DQA1*04:01, but at least three additional independent HLA haplotypes contribute to susceptibility. We used dense single nucleotide polymorphism (SNP) data in 2861 PBC cases and 8514 controls to impute classical HLA alleles and amino acid polymorphisms using state-of-the-art methodologies. We then demonstrated through stepwise regression that association in the HLA region can be largely explained by variation at five separate amino acid positions. Three-dimensional modelling of protein structures and calculation of electrostatic potentials for the implicated HLA alleles/amino acid substitutions demonstrated a correlation between the electrostatic potential of pocket P6 in HLA-DP molecules and the HLA-DPB1 alleles/amino acid substitutions conferring PBC susceptibility/protection, highlighting potential new avenues for future functional investigation.

Indexed as

Major Histocompatibility ComplexAmino Acid SequenceAmino Acid SubstitutionGenes, MHC Class IIGenetic Association StudiesGenetic Predisposition to DiseaseHLA AntigensHLA-C AntigensHLA-DP beta-ChainsHLA-DQ alpha-ChainsHLA-DQ beta-ChainsHLA-DRB1 ChainsHumansLiver Cirrhosis, BiliaryModels, GeneticModels, MolecularHLA AntigensHLA-C AntigensHLA-DPB1 antigenHLA-DP beta-ChainsHLA-DQA1 antigenHLA-DQ alpha-ChainsHLA-DQB1 antigenHLA-DQ beta-ChainsHLA-DRB1 Chains

Identifiers

PMID30507971
PMCPMC6292650
OpenAlexW2900952895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.